Crossref
Antiviral signaling at the maternal-fetal interface disrupts trophoblast fusion in preeclampsia
Placenta · 2026-09 · 183 · e237
DOI: 10.1016/j.placenta.2026.08.167 ↗Kurz gefasst
Fachartikel in der Zeitschrift Placenta, 2026-09. Verfasst von Yueshuang Lu und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Lu, Y., Grub, S., Li, D., Haußmann, I., Prodan, N., Salker, M. S., & Sauter, D. (2026). Antiviral signaling at the maternal-fetal interface disrupts trophoblast fusion in preeclampsia. Placenta, 183, e237. https://doi.org/10.1016/j.placenta.2026.08.167
Vancouver
Lu Y, Grub S, Li D, Haußmann I, Prodan N, Salker MS, et al. Antiviral signaling at the maternal-fetal interface disrupts trophoblast fusion in preeclampsia. Placenta. 2026;183:e237. doi:10.1016/j.placenta.2026.08.167
BibTeX
@article{Lu2026,
author = {Lu, Yueshuang and Grub, Susanne and Li, Duan and Haußmann, Isabell and Prodan, Natalia and Salker, Madhuri S. and Sauter, Daniel},
title = {Antiviral signaling at the maternal-fetal interface disrupts trophoblast fusion in preeclampsia},
journal = {Placenta},
year = {2026},
volume = {183},
pages = {e237},
doi = {10.1016/j.placenta.2026.08.167}
}
EUVIMED